Opvia Logo
Opvia Logo
Full visibility across Manufacturing and Quality teams in Skye Biologics

Customers

Full visibility across Manufacturing and Quality teams in Skye Biologics

quotation marks
Tali Kauffmann
Product Marketer at Opvia
2 minute read
Skye Biologics logo
Company

Skye Biologics

Size

51-200 employees

Industry
Biotechnology
Solution

A biotechnology leader since 2010, Skye Biologics has grown to be one of the world's leading independent new age biotechnology companies, and has reached hundreds of thousands of patients in the US with existing tissue products and is developing a pipeline of medicines with breakaway potential for decades to come.

Skye Biologics is committed to maximising therapeutic potential by harnessing the power of human biology to treat patients suffering from degenerative disease, damaged tissue, injury, and trauma. Skye is discovering and developing breakthrough therapeutics that optimise the repair process and lead to organised scar free advanced healing. Our novel approach begins with a platform of naturally advanced human biological material from which we unravel the code of complex molecules, isolating and applying them to treat a multitude of conditions. They are dedicated and strive to accelerate to market regenerative solutions that improve health outcomes and dramatically improve people's lives.

Skye Biologics's tissue implants have been used in over 250,000 tissue-repair treatments nationwide, to augment and support degenerated or damaged tissues in surgical repairs and non-operative therapy as a potential alternative to surgery. Their R&D team continues to work together with leading physicians, institutions, hospitals, to identify medical needs and continue to develop and tailor their unique products and and future biologic therapeutics.

Skye Biologics currently use Opvia for their manufacturing records and quality management system. The integration of these two areas enables them to efficiently track and manage data efficiently and effectively, and enables full visibility across the manufacturing and quality teams. The move to the Opvia platform has allowed Skye Biologics to improve operational efficiency by streamlining the production process and reducing time-to-release from a quality perspective, and tracking of production costs across batches has minimised shortages and overstock situations, thereby reducing costs.

Why should process manufacturers consider an electronic batch record (EBR) system?
Why should process manufacturers consider an electronic batch record (EBR) system?